{"id":"W2764047877","doi":"10.1182/blood.v128.22.5675.5675","title":"Efficacy of Carfilzomib in the Treatment of Relapsed and (or) Refractory Multiple myeloma: a Meta Analysis of Individual Patient Data from Clinical Trials","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Carfilzomib; Medicine; Multiple myeloma; Lenalidomide; Bortezomib; Meta-analysis; Clinical trial; Oncology; Internal medicine; Thalidomide; Proteasome inhibitor; Cochrane Library; Intensive care medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03353927,0.003373918,0.02188813,0.007301699,0.0006668767,0.004026521,0.002789067,0.002556034,0.003077317],"category_scores_gemma":[0.04333876,0.001888506,0.07229853,0.008913873,0.0008241781,0.002320847,0.00189081,0.002630796,0.0003644447],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001983607,"about_ca_system_score_gemma":0.001849435,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00478815,"about_ca_topic_score_gemma":0.006447516,"domain_scores_codex":[0.9707673,0.01791053,0.005644254,0.002947493,0.002109471,0.000620982],"domain_scores_gemma":[0.9649721,0.0262394,0.004816992,0.001786727,0.001701707,0.0004829929],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00218857,0.00001310202,0.003916522,0.02830069,0.9626896,0.00005416518,0.00001911963,0.0005788464,0.00009187852,0.0000571347,0.0001692164,0.001921092],"study_design_scores_gemma":[0.0005526227,0.0001213661,0.002843829,0.001473431,0.9939088,0.00003681718,0.00001548514,0.0003607871,0.00006577227,0.000183406,0.0004230868,0.00001454736],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02318168,0.970332,0.002806213,0.0004775207,0.0004290456,0.0003876659,0.001773435,0.00007711109,0.0005353658],"genre_scores_gemma":[0.7724743,0.2156981,0.004900681,0.001428382,0.0005075451,0.001349854,0.003019899,0.0001226453,0.000498483],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03353927,"threshold_uncertainty_score":0.1773747,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3327612388515309,"score_gpt":0.4480871288065761,"score_spread":0.1153258899550452,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}